Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Director Declaration

16 July 2020 07:00 BST     Director Declaration AstraZeneca PLC (the Company) today announced that Pascal Soriot, Chief Executive Officer of the Company, has been appointed as an independent Non-Executive Director of CSL Limited (ASX:CSL; USOTC:CSLLY), to be effective from 19 August 2020. This announcement is made pursuant to Listing Rule 9.6.14 R (2). AstraZenecaAstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of

Fabege acquires property and holding in the consortium SBD from WA Fastigheter

Flemingsberg is currently the site of Sweden’s biggest urban development project. Fabege has acquired the Regulatorn 2 property, which has a central location in the area and constitutes a key piece of the puzzle in the development of the district of Flemingsbergsdalen. In connection with the acquisition, an agreement has also been entered into with WA Fastigheter for Fabege to be the sole owner of the consortium SBD.Fabege will continue to work with Huddinge Municipality on the vision for, and development of Flemingsbergsdalen. The approach will be based on previous work that has been

DDM Holding AG and DDM Debt AB to report second quarter and half year 2020

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q2 and half year 2020 interim reports on Thursday 30 July 2020 at 08:00 CEST. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Austria: +43 192 822 09 Sweden:

REPORT ON THE SECOND QUARTER 2020

· Net sales for the quarter were 3,329 m (5,329); a decrease of -38%, of which -38% was organic growth. · Operating profit before depreciation and amortization (EBITDA) for the quarter was SEK 504 m (1,100), representing a margin of 15.1% (20.6%). · Operating profit (EBIT) before items affecting comparability for the quarter was SEK 361 m (900), representing a margin of 10.9% (16.9%). · Items affecting comparability for the quarter were SEK -61 m (-), of which SEK -61 m related to restructuring costs for the quarter from the global restructuring program. · Operating profit (EBIT)

Neste to publish its half-year results on 23 July 2020

Neste Corporation, Press Release, 16 July 2020 at 9 a.m. (EET) Neste will publish its half-year 2020 results on Thursday, 23 July 2020 at approximately 9 a.m. (EET). The release will be available on the Neste website  immediately after publishing. A conference call in English for investors and analysts will be held on 23 July 2020, at 3 p.m. Finland / 1 p.m. London / 8 a.m. New York. The call-in numbers are as follows: Finland: +358 (0) 9 4245 0806, rest of Europe: +44 (0) 20 7192 8000, US: +1 631 510 7495, using access code

AQ Group AB (publ), interim report January - June, 2020

Second quarter, April-June 2020in brief · Lower net sales due to Covid-19 but continued stable profit · Net sales decreased by 15.0% to SEK 1,116 million (1,313) · Operating profit (EBIT) decreased by 13.6% to SEK 81 million (93) · Profit after financial items (EBT) decreased by 11.7% to SEK 78 million (88) · Profit margin before tax (EBT %) was 7.0% (6.7) · Cash flow from operating activities increased to SEK 166 million (50) · Earnings per share after tax amounted to SEK 3.80 SEK (3.81) · Covid-19 affected the quarter by SEK 229 million lower net sales and

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2020

Stockholm, July 16, 2020. GomSpace Group AB (the “Company”) announces its interim report for the second quarter of 2020. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Second quarter summary 1 April – 30 June 2020 (2019) · Order intake decreased to T.SEK 42,342 (61,719) · Net revenues decreased to T.SEK 42,729 (52,224) · Gross margin decreased to 11% (23%) · Operating profit (loss) improved to a negative T.SEK 14,859 (a negative 42,328) · Earnings per share were a negative SEK 0.47 (a negative 0.

Changes in Outokumpu’s Leadership Team

Outokumpu OyjStock exchange releaseJuly 16, 2020 at 9.00 am EESTChanges in Outokumpu’s Leadership Team Liam Bates, B.Sc. hons Economics, MBA, has been appointed President, Long Products with immediate effect. Kari Tuutti, who has been leading business area Long Products since 2014, has decided to pursue his career outside Outokumpu. In his new position, Liam Bates will report to CEO Heikki Malinen, but he will not continue as a member of the Outokumpu Leadership Team. Liam Bates has been working at Outokumpu since 1993 in various positions including Business Development, Mergers &

Getinge Interim Report January-June 2020: Making a real difference together with our customers

“During this year’s second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry,” says Mattias Perjos, President & CEO Getinge. “We have received feedback from customers about the positive effect that our advanced ICU ventilators have had for treating COVID-19 patients, which is highly encouraging in our intensive efforts to gradually increase production of ventilators by 160% in 2020.”During the second quarter, Getinge has continued to work closely

DDM Holding AG and DDM Debt AB to report second quarter and half year 2020

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q2 and half year 2020 interim reports on Thursday 30 July 2020 at 08:00 CEST. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’sfinancial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Austria: +43 192 822 09 Sweden:

Local Thai Community-based Tourism attractions near Bangkok

For visitors who want to experience the local Thai way of life, tourist attractions close to Bangkok offer rich cultural experiences and responsible tourism options that are both sustainable and fun.Many of the local Thai community-based tourism attractions near Bangkok are specifically designed to support local community development and cultural conservation goals. Patronising local attractions like these often makes it easier for local Thai villagers to tackle important issues which affect the whole community; such as, nature conservation, waste management and preserving cultural

Interim Report – 3 months 1 April-30 June 2020

· Revenue amounted to MSEK 2,288 (1,576), with the change compared with the preceding year primarily attributable to the acquisition of Swedol.Compared with revenue for the corresponding quarter in the preceding year including Swedol (MSEK 2,499), revenue declined by 8 percent.*  · EBITA (excluding items affecting comparability of MSEK –4) amounted to MSEK 155 (75), corresponding to an EBITA margin of 6.8 percent (4.8). The change compared with the preceding year is primarily attributable to the acquisition of Swedol.Compared with EBITA for the corresponding quarter in the

Hansa Biopharma interim report Jan-Jun 2020

Hansa Biopharma reaches two landmark milestones: Idefirix (imlifidase) receives positive CHMP opinion in EU; Gene therapy partnership with Sarepta Therapeutics in select indications.Lund July 16, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and interim report for January – June, 2020. Highlights for the second quarter 2020 · CHMP/EMA has adopted a positive opinion, recommending conditional approval of Idefirix (imlifidase) for the desensitization treatment of highly sensitized adult kidney

Peab extends Pampus Port in Norrköping

Peab has been commissioned to extend Pampus Port on Händel Island in Norrköping. The customer is Norrköpings Hamn AB and the contract is worth SEK 345 million.The project entails a new 310 meter platform dock on piles, a 60 meter long heavy-lift dock and a new port area where goods can be stored. The project also includes laying new pipes for water and sewage and supplementary tonguing of the harbor basin to achieve the requisite depth for ship traffic everywhere in the harbor basin. Materials for the project will primarily be supplied from a nearby property at the disposal of Norrköpings

Fastighets AB Balder Interim report January-June 2020

· Profit from property management attributable to parent company shareholders amounted to SEK 1,993m (1,911), corresponding to an increase per share by 4 % to SEK 11.07 (10.61) · Long term net asset value amounted to SEK 354.98 per share (297.32) · Rental income amounted to SEK 4,049m (3,663) · Profit after tax attributable to parent company shareholders amounted to SEK 1,874m (2,621) corresponding to SEK 10.41 per share (14.56)  Profit from property management for the period amounted to SEK 2,347m (2,159). Profit from property management attributable to parent company

Sobi publishes report for the second quarter 2020

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces its results for the second quarter 2020. Total revenue for the second quarter 2020 was SEK 3,070 M and EBITA was SEK 1,018 M.  April—June · Total revenue of SEK 3,070 M (3,163), down 3 per cent (-4 per cent at constant exchange rates (CER)) · Adjusted EBITA[1,2]  was SEK 1,018 M (1,193), with an EBITA margin[1] of 33 per cent (33) · Earnings per share (EPS) of SEK 0.96 (1.70) and adjusted EPS[1,2,3] of 0.96 SEK (2.12) · Net debt[1] of SEK 11,802 M at 30 June 2020 (15,404 at 31 Dec 2019) ·

Fiskars to publish its Half-year Financial Report for January-June 2020 on July 30, 2020

Fiskars CorporationPress releaseJuly 16, 2020 at 09:00 (EEST) Fiskars to publish its Half-year Financial Report for January-June 2020 on July 30, 2020 Fiskars Corporation will publish its Half-year Financial Report for January-June 2020 on July 30, 2020 at approximately 8:30 a.m. (EEST). The report will be available on the company's website www.fiskarsgroup.com after publication.WebcastA webcast on the second quarter results will be held on July 30, 2020 at 11:00 a.m. It will be held in English and can be followed at: https://fiskars.videosync.fi/2020-q2-results 

Interim Report January-June 2020

Second quarter · Order intake amounted to SEK 651 (901) million, a decline of 28 percent · Net sales were SEK 1,086 (1,120) million, a decrease of 3 percent. The currency effect was insignificant. Net sales includes the delivery of a Prexision 10, which was brought forward on the initiative of the customer and was completed in the second quarter instead of the fourth quarter of the year as previously planned · EBIT was SEK 281 (317) million, a decline of 12 percent. The EBIT margin was 26 (28) percent  · The underlying EBIT was SEK 290 (332) million, a decline of 13 percent.

Elos Medtech Interim Report January 1 - June 30, 2020

A RAPID CONVERSION AND EFFICIENCY MEASURES DELIVER RESULTS  April - June 2020• Net sales for the second quarter amounted to SEK 118.3 million (184.1), a decrease of 35.7 percent compared to the same period last year. After currency translation, the decrease was 36.2 percent.• Operating profit was SEK 14.9 (15.6) million, which represents an operating margin of 12.6 (8.5) percent.• Operating profit has been positively affected by SEK 37 million with respect to government support received owing to Covid-19.• The profit after financial items amounted to SEK 9.1 (8.6) million. Net

Orexo Interim Report Q2 2020

Investing in diversification to drive future growth  Q2 2020 highlights · Total net revenues of SEK 179.1 m (201.2) · EBITDA of SEK -9.0 m (60.4), positive EBITDA of SEK 26.5 m (60.4) excluding accelerated DTx US launch  · Net earnings of SEK -32.5 m (54.6), positive net earnings SEK 3.0 m (54.6) excluding accelerated DTx US launch · US Pharma (ZUBSOLV® US) net revenues of SEK 172.5 m (184.4), EBIT of SEK 88.8 m (83.8)  · DTx  EBIT of SEK -35.5 m (-) · Cash flow from operating activities of SEK -7.2 m (46.1), a cash balance of SEK 677.2 m (697.0) · Completed the

Investor Report

RBC Covered Bond Programme Monthly Investor Report Calculation Date:                          6/30/2020     This report containsinformation regardingassets pledged assecurity (the Cover Pool)in respect of theobligations under theCovered Bonds issuedunder RBC's GlobalCovered Bond Programme asof the indicatedCalculation Date. Thecomposition of the CoverPool will change as Loansare added and removedfrom the Cover Pool fromtime to time and,accordingly, thecharacteristics andperformance of the Loansin the Cover Pool willvary over time. Certainof

Basware Half Year Financial Report January-June 2020: Better than expected performance driven by consistent execution despite Covid-19

Basware Corporation, stock exchange release, July 16, 2020 at 8.45 am EESTApril-June 2020 · Cloud ARR order intake amounted to EUR 6.1 million (EUR 6.4 million) · Net sales increased 4.0 percent to EUR 37,769 thousand (EUR 36,320 thousand), which amounted to 4.5 percent organic growth at constant currencies · Cloud revenue increased 8.4 percent to EUR 26,841 thousand (EUR 24,752 thousand), which amounted to 8.8 percent organic growth at constant currencies. · EBIT amounted to EUR 1,285 thousand (EUR -6,181 thousand) · Earnings per share (diluted) were EUR -0.07 (EUR -0.65)

BE Group Q2 2020 - Improved gross margin and underlying result in line with last year

Second quarter · Net sales amounted to SEK 935 M (1,193) · The underlying operating result amounted to SEK 28 M (32) · The quarter was affected by items affecting comparability of SEK -5 M (-) related to the centralization of warehouse and production operations in the Baltics · The operating result amounted to SEK 21 M (32) · Result after tax amounted to SEK 18 M (19) · Cash flow from operating activities amounted to SEK 95 M (67) · Earnings per share amounted to SEK 1.34 (1.44) Statement from the CEOWe entered the second quarter with great uncertainty due to the

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release July 16, 2020, at 8:45 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on July 15, 2020, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement BlackRock, Inc.'s indirect holding in Nokian Tyres shares fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on July 14, 2020. The indirect shareholding of BlackRock, Inc. in Nokian Tyres has decreased to 6,205,220 shares, corresponding to 4.46% of Nokian Tyres’ shares and

There are no items matching the current filter
There are no more items matching the current filter
Back to top